SPACs
SPACs are an alternative method of accessing the public equity markets and are best suited for growth-oriented healthcare and technology companies that are leaders of the innovation economy.
Contact UsOverview
Our SPAC Group has deep expertise in the structuring and execution of transactions across the full SPAC cycle, offering the full suite of capabilities across SPAC IPO underwriting, De-SPAC Advisory and PIPE execution.
Related Transactions
See all transactions
UNDISCLOSED
Capital Markets Advisor
Merger with European Biotech Acquisition Corp.
Pending
UNDISCLOSED
Financial Advisor and Capital Markets Advisor
Merger with Frazier Lifesciences Acquisition Corp.
November 2022
$120 Million
Financial Advisor
Initial Public Offering
June 2022
$115 Million
Co-Lead Placement Agent
Private Placement
April 2022
UNDISCLOSED
Financial Advisor
Merger with MoonLake Immunotherapeutics
April 2022
UNDISCLOSED
Capital Markets and Financial Advisor
Merger with Avista Public Acquisition Corp. II
Pending
$200 Million
Sole Bookrunning Manager
Initial Public Offering
February 2022
$124 Million
Co-Placement Agent
PIPE
February 2022
UNDISCLOSED
Financial & Capital Markets Advisor
Merger with Environmental Impact Acquisition Corp.
February 2022
UNDISCLOSED
Capital Markets Advisor
Merger with Montes Archimedes Acquisition Corp.
September 2021
$200 Million
Lead Placement Agent
PIPE
September 2021
UNDISCLOSED
Financial Advisor
Merger with Tango Therapeutics
August 2021